The analysis of cellular mechanisms underlying haematopoietic stem cell (HSC) development using a novel in vitro system
The analysis of cellular mechanisms underlying haematopoietic stem cell (HSC) development using a novel in vitro system
批准号:
BB/D01347X/1
负责人:
Alexander Medvinsky
金额:
$51.61万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --
中文摘要
哺乳动物体内的各种红细胞和白细胞都是由骨髓中的少数细胞产生的。在这个项目中,我们将研究血液干细胞如何在哺乳动物胚胎中产生。血液干细胞在AGM区域发育,该区域包括一条大血管(背主动脉)、胚胎性腺和肾脏。这里将提出两个主要问题:1)胚胎中发育成血液干细胞的细胞是什么?ii)诱导或促进这一过程的辅助细胞是什么?直到最近,由于缺乏适当的实验模型,还不可能解决这些问题。我们已经开发了一个实验系统,使我们能够培养和操纵来自小鼠AGM区域的未成熟细胞并产生血液干细胞。该系统将用于测试不同类型的细胞发育成血液干细胞或支持干细胞形成的能力。为此,胚胎中不同类型的细胞将用特定试剂(抗体)染色,并通过一种称为荧光激活细胞分选器(FACS)的机器分离出来。然而,某些重要的细胞类型不能用抗体分离。因此,我们将使用在实验室中产生的转基因小鼠。在两种转基因小鼠模型中,已知与干细胞发育相关的AML1和HoxB4基因被标记为绿色和黄色荧光报告分子。这些荧光标记将允许我们通过FACS分离AML1和HoxB4细胞,并分析它们在培养系统中在干细胞中发育的能力。该项目的一个补充和重要方面是研究使用我们的培养系统从胚胎干细胞(称为ES细胞)中产生血液干细胞的可能性。胚胎干细胞可用于制造完整的成年小鼠。因此,它们能够在小鼠体内产生包括血液干细胞在内的所有细胞类型。在研究人员以前使用的传统培养条件下,胚胎干细胞只能产生成熟的血细胞,而不能产生血液干细胞。利用我们的新系统,通过共同培养胚胎干细胞和AGM细胞,我们将能够确定胚胎干细胞是否可以在AGM细胞的影响下产生血液干细胞。在这里,我们将再次通过FACS从培养的胚胎干细胞中分离细胞群,并在该系统中进行测试。该项目将提供更好的理解,不仅血液干细胞的生物学,而且其他干细胞。这也将对培养血液干细胞的产生和繁殖具有重要的实际意义。
英文摘要
The entire variety of red and white blood cells in mammals is generated by a small number of cells in the bone marrow. In this project we will investigate how blood stem cells are generated in the mammalian embryo. Blood stem cells develop in the area called the AGM region which encompasses a large vessel (the dorsal aorta) and embryonic gonads and kidneys. Two main questions will be asked here: i) what are the cells in the embryo which develop into blood stem cells? and ii) what are the helper cells which induce or facilitate this process? Until recently, owing to lack of an adequate experimental model it has not been possible to address these issues. We have developed an experimental system which allows us to culture and manipulate immature cells from the mouse AGM region and generate blood stem cells. This system will be used to test the ability of different cell types to develop into blood stem cells or to support stem cell formation. To this end different cell types from the embryo will be stained with specific reagents (antibodies) and isolated by a machine called fluorescence-activated cell sorter (FACS). However, certain important cell types cannot be isolated using antibodies. Therefore we will use genetically modified transgenic mice generated in the laboratory. In two such transgenic mouse models AML1 and HoxB4 genes known to be associated with stem cell development are labelled with green and yellow fluorescent reporter molecules. These fluorescent tags will allow us to isolate AML1 and HoxB4 cells by FACS and analyse their ability to develop in stem cells in the culture system. A complementary and important aspect of this project is to investigate the possibility of using our culture system for the generation of blood stem cells from embryonic stem cells (known as ES cells). ES cells can be used to produce entire adult mice. They are thus capable of generating all cell types in the mouse including blood stem cells. In traditional culture conditions previously used by researchers ES cells could only produce mature blood cells but not blood stem cells. Using our novel system by co-culturing ES cells and AGM cells we will be able to determine whether ES cells can generate blood stem cells under the influence of AGM cells. Here again we will isolate cell populations from cultured ES cells by FACS and test them in this system. This project will provide better understanding not only of biology of blood stem cells but also of other stem cells. It will also have important practical implications for generation and propagation of blood stem cells in culture.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/9780470151808.sc02a06s4
发表时间:
2008
期刊:
Current protocols in stem cell biology
影响因子:
--
作者:
[A. Medvinsky;S. Taoudi;Sandra Mendes;E. Dzierzak]
通讯作者:
A. Medvinsky;S. Taoudi;Sandra Mendes;E. Dzierzak
DOI:
10.1242/dev.110841
发表时间:
2014-09
期刊:
Development (Cambridge, England)
影响因子:
--
作者:
[Liakhovitskaia A, Rybtsov S, Smith T, Batsivari A, Rybtsova N, Rode C, de Bruijn M, Buchholz F, Gordon-Keylock S, Zhao S, Medvinsky A]
通讯作者:
Medvinsky A
DOI:
10.1084/jem.20111688
发表时间:
2011-11-21
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Ivanovs A, Rybtsov S, Welch L, Anderson RA, Turner ML, Medvinsky A]
通讯作者:
Medvinsky A
Validation of biomarkers predicting clinical outcomes of umbilical cord blood transplantation
-
批准号:MR/W029669/1
-
项目类别:Research Grant
-
资助金额:$214.79万
-
财政年份:2023
-
负责人:Alexander Medvinsky
-
依托单位:
Analysis of biomechanical forces in the embryonic development of haematopoietic stem cells
-
批准号:BB/W003236/1
-
项目类别:Research Grant
-
资助金额:$92.08万
-
财政年份:2022
-
负责人:Alexander Medvinsky
-
依托单位:
UNDERSTANDING MOLECULAR MECHANISMS UNDERLYING DEVELOPMENT OF HIGHLY REGENERATIVE HUMAN HAEMATOPOIETIC STEM CELLS
-
批准号:MR/V030043/1
-
项目类别:Research Grant
-
资助金额:$91.8万
-
财政年份:2021
-
负责人:Alexander Medvinsky
-
依托单位:
IDENTIFICATION OF A NOVEL ANGIOPOIETIN 2 SIGNALLING CENTRE IN THE EMBRYONIC HAEMATOPOIETIC STEM CELL NICHE
-
批准号:MR/R018081/1
-
项目类别:Research Grant
-
资助金额:$80.62万
-
财政年份:2018
-
负责人:Alexander Medvinsky
-
依托单位:
Tracking the embryonic origin of the adult haematopoietic system
-
批准号:MR/L018160/1
-
项目类别:Research Grant
-
资助金额:$101.23万
-
财政年份:2014
-
负责人:Alexander Medvinsky
-
依托单位:
DEVELOPMENT OF A NON-INVASIVE STRATEGY ENHANCING HAEMATOPOIETIC STEM CELL (HSC) POTENTIAL OF HUMAN UMBILICAL CORD CELLS
-
批准号:G0901577/1
-
项目类别:Research Grant
-
资助金额:$88.88万
-
财政年份:2011
-
负责人:Alexander Medvinsky
-
依托单位:
Identification of functional domains in the AGM region linked to the hierarchical organisation of the developing haematopoietic stem cell lineage
-
批准号:BB/H008780/1
-
项目类别:Research Grant
-
资助金额:$164.57万
-
财政年份:2010
-
负责人:Alexander Medvinsky
-
依托单位:
ANALYSIS OF MECHANISMS OF EARLY HAEMATOPOIETIC STEM CELL DEVELOPMENT CONTROLLED BY FLK1/SCL REGULATORY NETWORK
-
批准号:G0900962/1
-
项目类别:Research Grant
-
资助金额:$158.35万
-
财政年份:2010
-
负责人:Alexander Medvinsky
-
依托单位:
Role of AML1/Runx1 isoforms in development, self-renewal and differentiation of haematopoietic progenitor/stem cells
-
批准号:G0500950/1
-
项目类别:Research Grant
-
资助金额:$59.65万
-
财政年份:2006
-
负责人:Alexander Medvinsky
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
-
批准号:82371144
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汪雪玲
-
依托单位:
长寿基因SIRT7调控核苷酸切除修复通路的机制研究
-
批准号:32100605
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:耿安珂
-
依托单位:
溶酶体蛋白LAPTM4B通过与Xc-系统相互作用调控谷胱甘肽代谢的机制研究
-
批准号:32100623
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周可成
-
依托单位:
小鼠肺分支早期发育中肺上皮单细胞的时-空转录组的建立与分析
-
批准号:32070795
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:蔡军
-
依托单位:
乳腺癌上皮间质转化中核苷酸代谢相关的功能蛋白发现和机理研究
-
批准号:32070748
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2020
-
负责人:戴凌云
-
依托单位:
rhTβ4增强间充质干细胞调节T细胞代谢重塑治疗干眼的机制研究
-
批准号:32000530
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:陈小鸟
-
依托单位:
胰岛素和细菌信号协同调节巨噬细胞免疫反应的作用
-
批准号:92057105
-
项目类别:重大研究计划
-
资助金额:89.0万元
-
批准年份:2020
-
负责人:Tiffany Shy Yea Horng
-
依托单位:
胞浆甘氨酰-tRNA合成酶cytoGARS感知甘氨酸的分子机制及其对肝细胞癌的影响
-
批准号:32070756
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2020
-
负责人:汪维
-
依托单位:
ORP8调控脂滴自噬的作用和机制研究
-
批准号:92057203
-
项目类别:重大研究计划
-
资助金额:295.0万元
-
批准年份:2020
-
负责人:刘伟
-
依托单位:
一种全新的高尔基体胆固醇感应蛋白的鉴定和功能研究
-
批准号:32070755
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:钟辉
-
依托单位: